Relief Therapeutics obtiene una patente europea para el nuevo compuesto RLF-TD011, garantizando derechos exclusivos. Relief Therapeutics gets European patent for new compound RLF-TD011, securing exclusive rights.

Relief Therapeutics ha recibido una concesión de patente de la Oficina Europea de Patentes por su compuesto RLF-TD011. Relief Therapeutics has received a patent grant from the European Patent Office for their compound RLF-TD011. Este desarrollo es un hito importante para la empresa, ya que les otorga derechos exclusivos sobre el complejo en Europa durante un período determinado. This development is a significant milestone for the company, as it provides them with exclusive rights to the compound in Europe for a set period. RLF-TD011 es un compuesto terapéutico, aunque en el anuncio no se facilitaron detalles específicos sobre su uso. RLF-TD011 is a therapeutic compound, though specific details about its use were not provided in the announcement.